Publications

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, vol.129, pp.634-643, 2021 (SCI-Expanded)

Activation-Induced Cytidine Deaminase (AID) and Uracil N-glycosylase (UNG) novel homozygous gene variants in adult hyper-IgM syndrome

YİLMAZ H., Firtina S., Saritas M., AR M. C., SAYİTOĞLU M.

EUROPEAN JOURNAL OF IMMUNOLOGY, vol.51, pp.374, 2021 (SCI-Expanded)

Kronik Lenfositik Losemide Genetik Ozellikler ve TP53 Mutasyonu

ERDOĞAN ÖZÜNAL I., ELVERDİ T., EŞKAZAN A. E., SALİHOĞLU A., AR M. C., ÖNGÖREN Ş., et al.

Cerrahpaşa Medical Journal, 2021 (Peer-Reviewed Journal)

Metformin reverses the effects of high glucose on human dermal fibroblasts of aged skin via downregulating RELA/p65 expression

Soydas T., Sayitoglu M., Sarac E. Y., Cinar S., Solakoglu S., Tiryaki T., et al.

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, vol.77, no.3, pp.443-450, 2021 (SCI-Expanded)

Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations

Giardino G., Sharapova S. O., Ciznar P., Dhalla F., Maragliano L., Devi A. R. R., et al.

JOURNAL OF CLINICAL IMMUNOLOGY, vol.41, no.4, pp.756-768, 2021 (SCI-Expanded) Sustainable Development

Differential Expression of LEF1 Isoforms in Adult Lymphoid and Myeloid Malignancies

Fırtına S., Ng Ö. H., Erbilgin Y., Haznedaroğlu İ., Sayitoğlu M.

EXPERIMED, vol.11, no.3, pp.184-188, 2021 (Scopus)

Differential Expression of LEF1 Isoforms in Adult Lymphoid and Myeloid Malignancies

FIRTINA S., HATIRNAZ NG Ö., ERBİLGİN Y., HAZNEDAROĞLU İ. C., SAYİTOĞLU M.

Experimed, vol.11, 2021 (Peer-Reviewed Journal)

Mutational landscape of severe combined immunodeficiency patients from Turkey.

Firtina S., Yin N., Hatirnaz N., Kiykim A., Aydiner E., Nepesov S., et al.

International journal of immunogenetics, vol.47, no.6, pp.529-538, 2020 (SCI-Expanded)

HighTUBB2Aexpression in childhood T-ALL is correlated with the clinical outcome

Khodzhaev K., Ng O. H., Tuğcu D., Erbilgin Y., Ng Y. Y., Celkan T., et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, vol.42, no.5, pp.581-588, 2020 (SCI-Expanded)

Hydrogen Sulphide and Nitric Oxide Cooperate in Cardioprotection Against Ischemia/Reperfusion Injury in Isolated Rat Heart.

Ustunova S., Takir S., Yilmazer N., Bulut H., Altindirek D., Ng O., et al.

In vivo (Athens, Greece), vol.34, pp.2507-2516, 2020 (SCI-Expanded)

Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect

Khodzhaev K., Bay S., Kebudi R., Altindirek D., Kaya A., Erbilgin Y., et al.

JOURNAL OF CLINICAL IMMUNOLOGY, vol.40, no.6, pp.883-892, 2020 (SCI-Expanded) Sustainable Development

MIR223 Gene Silencing via Locked Nucelic Acids in Cell Lines

Sayitoğlu M., Hatırnaz Ng Ö.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol.3, no.2, pp.45-50, 2020 (Peer-Reviewed Journal) Sustainable Development

Whole Genome RNA Sequencing Analysis Algorithm in Leukemia Model

Sayitoğlu M.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi , vol.3, no.2, pp.26-34, 2020 (Peer-Reviewed Journal) Sustainable Development

Copy number variations in adult patients with chronic immune thrombocytopenia.

Yucesan E., Hatirnaz N., Yalniz F., Yilmaz H., Salihoglu A., Sudutan T., et al.

Expert review of hematology, vol.13, pp.1277-1287, 2020 (SCI-Expanded) Sustainable Development

PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia

Küçükcankurt F., Erbilgin Y., Fırtına S., Hatırnaz N., Karakaş Z., Celkan T., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.2, pp.98-103, 2020 (SCI-Expanded, Scopus, TRDizin)

Prognostic gene alterations and clonal changes in childhood B-ALL

Erbilgin Y., Firtina S., Mercan S., Ng O. H., Karaman S., Tasar O., et al.

LEUKEMIA RESEARCH, vol.83, 2019 (SCI-Expanded, Scopus)

; The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma

Sakai B., Sayitoglu M., Istemihan Z., Karan M. A., Erten N., Dogan O., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.36, no.3, pp.178-185, 2019 (SCI-Expanded)

A Novel FOXN1 Variant Is Identified in Two Siblings with Nude Severe Combined Immunodeficiency

Firtina S., Cipe F., Ng Y. Y., Kiykim A., Ng O. H., Sudutan T., et al.

JOURNAL OF CLINICAL IMMUNOLOGY, vol.39, pp.144-147, 2019 (SCI-Expanded)

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors

Erbilgin Y., Eskazan A. E., Ng O. H., Salihoglu A., Elverdi T., Firtina S., et al.

LEUKEMIA & LYMPHOMA, vol.60, pp.200-207, 2019 (SCI-Expanded)

Germline mutations of aryl hydrocarbon receptor-interacting protein (AIP) gene and somatostatin receptor 1-5 and AIP immunostaining in patients with sporadic acromegaly with poor versus good response to somatostatin analogues

Ozkaya H. M., Comunoglu N., Sayitoglu M., Keskin F. E., Firtina S., Khodzhaev K., et al.

PITUITARY, vol.21, pp.335-346, 2018 (SCI-Expanded)

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

Ongoren S., Eskazan A. E., Suzan V., Savci S., Ozunal I. E., Berk S., et al.

Hematology (Amsterdam, Netherlands), vol.23, no.4, pp.212-220, 2018 (SCI-Expanded)

8q24 bölgesi çocukluk çağı lenfoblastik lösemiler için potansiyel risk oluşturur mu?

HATIRNAZ N. Ö., can i., FIRTINA S., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

Deneysel Tıp Dergisi, 2018 (Peer-Reviewed Journal)

Prevalence and effect evaluation of FLT3 and NPM1 mutations in acute myeloid leukemia patients in eastern Algeria

Ayachı O. S., Rezgoun M. L., Sayitoglu M., Altindirek D., Erbilgin Y., Abadı N., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, vol.28, no.3, pp.169-179, 2018 (SCI-Expanded)

Kronik Myeloid Lösemide BCR-ABL Füzyon Transkriptinin Eş Zamanlı PCR ile Kantitasyonu İçin Referans Plazmid Oluşturulması

NG Y. Y., Yılmaz Z. H., HATIRNAZ NG Ö., SAYİTOĞLU M.

Deneysel Tıp Araştırma Enstitüsü Dergisi, vol.7, no.13, pp.93-100, 2017 (Peer-Reviewed Journal)

A novel pathogenic frameshift variant of CD3E gene in two T-B+ NK+ SCID patients from Turkey.

Firtina S., Ng Y. Y., Ng O. H., Nepesov S., Yesılbas O., Kilercik M., et al.

Immunogenetics, vol.69, pp.653-659, 2017 (SCI-Expanded)

Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia.

Fırtına S., Hatırnaz N. O., Erbilgin Y., Özbek U., Sayitoğlu M.

Turkish journal of medical sciences, vol.47, pp.357-363, 2017 (SCI-Expanded)

Aberrant Hypermethylation of APC Tumor Supressor Gene in Acute Leukemia Patients

Hatirnaz O. N. G., Firtina S., Erbilgin Y., Özbek U., Sayitoglu M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.27, pp.1-7, 2017 (SCI-Expanded)

Çocukluk Çag ı Akut Lenfoblastik Lösemide Genetik Belirteçler

ERBİLGİN Y., ÖZBEK U.

Turkiye Klinikleri J Pediatr Sci, vol.12, no.4, 2016 (Peer-Reviewed Journal)

Clinical Interpretation of Genomic Variations.

Sayitoğlu M.

Turkish journal of haematology : official journal of Turkish Society of Haematology, vol.33, pp.172-9, 2016 (SCI-Expanded)

Does 8q24 region have a potentil risk for childhood acute lymphoblastic leukemia?

Hatırnaz Ö., Can İ., Fırtına S., Erbılgın Y., Özbek U., Sayitoğlu M.

Deneysel Tıp Dergisi, vol.3, no.9, pp.3-6, 2016 (Peer-Reviewed Journal)

Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells.

Oztopcu-Vatan P., Sayitoglu M., Gunındı M., Inan E.

Cytotechnology, vol.67, pp.1003-9, 2015 (SCI-Expanded)

High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.

Numata M., Yener M. D., Ekmekci S., Aydin M., Grosveld G., Cardone M., et al.

Leukemia research, vol.39, pp.906-12, 2015 (SCI-Expanded)

First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Isil Barlan in Turkey

Ng Y. Y., Sisko S., Ng O. H., Tatonyan S. C., Kaya D., Firtina S., et al.

TURKISH JOURNAL OF IMMUNOLOGY, vol.3, no.2, pp.47, 2015 (ESCI)

A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia

Ng O. H., Firtina S., Can I., Karakas Z., Agaoglu L., Dogru O., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.32, pp.127-135, 2015 (SCI-Expanded, Scopus, TRDizin)

Association of three SNPs in the PARP-1 gene with Hashimoto's thyroiditis.

KOC A., Aydin S., KARAKURT F., BATAR B., NIYAZOGLU M., CELIK O., et al.

Human genome variation, vol.1, pp.14016, 2014 (Scopus)

Local Renin-Angiotensin system in normal hematopoietic and multiple myeloma-related progenitor cells.

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology, vol.31, no.2, pp.136-42, 2014 (SCI-Expanded)

Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort

Niyazoglu M., Sayitoglu M., Firtina S., Hatipoglu E., Gazioglu N., Kadioglu P.

PITUITARY, vol.17, no.3, pp.220-226, 2014 (SCI-Expanded)

Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia.

Ng O. H., Erbilgin Y., Firtina S., Celkan T., Karakas Z., Aydogan G., et al.

Blood cancer journal, vol.4, 2014 (SCI-Expanded, Scopus) Sustainable Development

Parathyroid allotransplantation in rabbits without cultivation

Can I., Aysan E., Yucesan E., Sayitoglu M., Ozbek U., Ercivan M., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.7, no.1, pp.280-284, 2014 (SCI-Expanded)

Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases

Bento C., Percy M. J., Gardie B., Magalhaes Maia T., van Wijk R., Perrotta S., et al.

HUMAN MUTATION, vol.35, no.1, pp.15-26, 2014 (SCI-Expanded)

Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders.

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.

Journal of the renin-angiotensin-aldosterone system : JRAAS, vol.14, no.4, pp.308-14, 2013 (SCI-Expanded)

Expression analysis and clinical correlation of aquaporin 1 and 4 genes in human hippocampal sclerosis

Bebek N., Özdemir Ö., Sayitoglu M., Hatirnaz O., Baykan B., Gurses C., et al.

JOURNAL OF CLINICAL NEUROSCIENCE, vol.20, no.11, pp.1564-1570, 2013 (SCI-Expanded)

LOW PLATELET COUNTS AS A PROGNOSTIC MARKER IN ALL TREATMENT IN PLACE OF MRD IN COUNTRIES WITH LIMITED FINANCIAL RESOURCES

Celkan T., Koka A., Özdemir N., Tuysuz G., Apak H., Erginoz E., et al.

PEDIATRIC BLOOD & CANCER, vol.60, pp.191, 2013 (SCI-Expanded)

LOCAL HEMATOPOIETIC RENIN-ANGIOTENSIN SYSTEM IN MYELOID VERSUS LYMPHOID HEMATOLOGICAL NEOPLASTIC DISORDERS

Uz B., Haznedaroglu I., Sayinalp N., Ozcebe O., Buyukasik Y., Goker H., et al.

HAEMATOLOGICA, vol.98, pp.768, 2013 (SCI-Expanded)

LOCAL RENIN-ANGIOTENSIN SYSTEM IN NORMAL HEMATOPOIETIC AND MULTIPLE MYELOMA-RELATED PROGENITOR CELLS

Haznedaroglu I., Uz B., Ozcebe O., Buyukasik Y., Goker H., Aksu S., et al.

HAEMATOLOGICA, vol.98, pp.768, 2013 (SCI-Expanded)

Parallel Visualization of Multiple Protein Complexes in Individual Cells in Tumor Tissue

Leuchowius K., Clausson C., Grannas K., Erbilgin Y., Botling J., Zieba A., et al.

MOLECULAR & CELLULAR PROTEOMICS, vol.12, no.6, pp.1563-1571, 2013 (SCI-Expanded) Sustainable Development

Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.4, pp.264-268, 2013 (SCI-Expanded)

Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Sayitoglu M., Erbilgin Y., Ng O. H., Yildiz I., Celkan T., Anak S., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology, vol.29, no.4, pp.325-33, 2012 (SCI-Expanded)

Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.

Hannon M. M., Lohan F., Erbilgin Y., Sayitoglu M., O'hagan K., Mills K., et al.

British journal of haematology, vol.158, no.5, pp.626-34, 2012 (SCI-Expanded)

Akut lösemi hücre serilernde Beta-Katenin siRNA uygulamaları.

NG Hatirnaz O., Erbilgin Y., ÇETİN E., DENİZ G., Ozbek U., Sayitoglu M.

Deneysel Tıp Dergisi, vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

Genetic alterations in members of the Wnt pathway in acute leukemia

Erbilgin Y., Ng O. H., Mavi N., Ozbek U., Sayitoglu M.

LEUKEMIA & LYMPHOMA, vol.53, pp.508-510, 2012 (SCI-Expanded)

Akut lösemi hücre serilerinde beta-katenin sirna uygulamaları

HATIRNAZ O., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

Deneysel Tıp Dergisi, vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

Akut Lösemi Hücre Serilerinde Beta-Katenin siRNA Uygulamaları

HATIRNAZ NG Ö., ERBİLGİN Y., AKTAŞ E., DENİZ G., ÖZBEK U., SAYİTOĞLU M.

Deneysel Tıp Araştırma Enstitüsü Dergisi, vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.

Firtina S., Sayitoglu M., Hatirnaz O., Erbilgin Y., Oztunc C., Cinar S., et al.

Leukemia research, vol.36, no.1, pp.87-92, 2012 (SCI-Expanded, Scopus)

Akut Lösemi Hücre serilerinde beta katenin siRNA uygulamaları

SAYİTOĞLU M.

Deneysel Tıp, vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

Protein-protein ilişkilerini belirlemede yeni bir yöntem: proksimiti Ligasyon Assay (yakınsal bağlanma tepiti).

Erbilgin Y., HATIRNAZ O., SAYİTOĞLU M., Söderberg O., ÖZBEK U.

Deneysel Tıp Dergisi, vol.1, no.2, pp.24-27, 2012 (Peer-Reviewed Journal)

Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?

Eskazan A. E., Soysal T., Erbilgin Y., Ozbek U., Ferhanoglu B.

LEUKEMIA RESEARCH, vol.35, no.9, 2011 (SCI-Expanded)

Sequence variations of NKX2-5 and HAND1 genes in patients with atrial isomerism.

Hatemi A. C., Gulec Ç., Cine N., Vural B., Hatirnaz O., Sayitoglu M., et al.

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, vol.11, no.4, pp.319-28, 2011 (SCI-Expanded)

BETA KATENİN VE AXIN2 PROTEİNLERİ ETKİLEŞİMLERİNİN PROKSİMİTİ LİGASYON ASSAY YAKINSAL BAĞLANMA TESPİTİ ILE GÖRÜNTÜLENMESİ

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., SÖDERBERG O., ÖZBEK U.

DENEYSEL TIP DERGİSİ, vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)

ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method

Erbilgin Y., Catal S., Eskazan A. E., Hatirnaz O., Soysal T., Ozbek U.

TURKISH JOURNAL OF HEMATOLOGY, vol.28, no.2, pp.97-102, 2011 (SCI-Expanded)

ß Katenin ve Axin2 proteinleri etkileşimlerinin Proksimiti LigasyonAssay Yakınsal Bağlanma Tespiti ile görüntülenmesi

ERBİLGİN Y., SAYİTOĞLU M., SODERBERG O., HATIRNAZ NG Ö., ÖZBEK U.

Deneysel Tıp Dergisi, vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation

Uz B., Bektas O., Eliacik E., GÖKER H., ERBİLGİN Y., SAYİTOĞLU M., et al.

CASE REPORTS IN HEMATOLOGY, 2011 (ESCI)

Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL

Erbilgin Y., Sayitoglu M., Hatirnaz O., Dogru O., Akçay A., TUYSUZ G., et al.

DISEASE MARKERS, vol.28, no.6, pp.353-360, 2010 (SCI-Expanded)

Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.

Sayitoglu M., Haznedaroğlu İ. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.

The Journal of international medical research, vol.37, no.4, pp.1018-28, 2009 (SCI-Expanded)

Bone Marrow Renin-Angiotensin System in Multiple Myeloma

SAKA B., DOGAN O., TASCIOGLU C., BESISIK S., KARAN M. A., Sayitoglu M., et al.

CLINICAL LYMPHOMA & MYELOMA, vol.9, 2009 (SCI-Expanded)

Glucocorticoid receptor gene polymorphisms and their relation with glucocorticoid sensitivity and obesity in patients with congenital adrenal hyperplasia

Saka N., Poyrazoglu S., Sayitoglu M., Ozbek U., Sen N., ISGUVEN P., et al.

HORMONE RESEARCH, vol.72, pp.346, 2009 (SCI-Expanded) Sustainable Development

Minimal Residual Disease (MRD) Detection with Translocations and T-Cell Receptor and Immunoglobulin Gene Rearrangements in Adult Acute Lymphoblastic Leukaemia Patients: A Pilot Study.

Sayitoğlu M., Ar M. C., Hatırnaz Ö., ÖNGÖREN Ş., ÜRE Ü., Başlar Z., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology, vol.25, pp.124-32, 2008 (SCI-Expanded)

Aromatase cytochrome P450 enzyme expression in human pituitary

Kadioglu P., Oral G., Sayitoglu M., Erensoy N., Senel B., Gazioglu N., et al.

PITUITARY, vol.11, pp.29-35, 2008 (SCI-Expanded)

Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas.

Gazioglu N., Erensoy N., Kadioglu P., Sayıtıoglu M., Ersoy I. H., Hatımaz O., et al.

Medical science monitor : international medical journal of experimental and clinical research, vol.13, 2007 (SCI-Expanded)

Cancer therapy and pharmacogenetic approach: Scientific letter

Sayitoglu M.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.27, no.3, pp.434-441, 2007 (SCI-Expanded) Sustainable Development

Kanser Tedavisine Farmakogenetik Yaklaşım

AYDIN SAYİTOĞLU M.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.27, no.3, pp.10-12, 2007 (Scopus) Sustainable Development

Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias

Aydin-Sayitoglu M., Hatirnaz O., Erensoy N., Ozbek U.

AMERICAN JOURNAL OF HEMATOLOGY, vol.81, pp.162-170, 2006 (SCI-Expanded)

Common cytochrome p4503A (CYP3A4 and CYP3A5) and thiopurine S-methyl transferase (TPMT) polymorphisms in Turkish population

Aydin Sayitoǧlu M., Yildiz I., Hatirnaz Ö., Özbek U.

Turkish Journal of Medical Sciences, vol.36, no.1, pp.11-15, 2006 (SCI-Expanded)

Prox1 activity controls pancreas morphogenesis and participates in the production of "secondary transition" pancreatic endocrine cells

Wang J., Kılıç G., Aydin M., Burke Z., Olıver G., Sosa-Pıneda B.

DEVELOPMENTAL BIOLOGY, vol.286, pp.182-194, 2005 (SCI-Expanded) Sustainable Development

CYP2D6 and CYP1A1 mutations in the Turkish population

Aydin M., Hatirnaz O., ERENSOY N., OZBEK U.

CELL BIOCHEMISTRY AND FUNCTION, vol.23, no.2, pp.133-135, 2005 (SCI-Expanded) Sustainable Development

Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias

Akyerli C., ÖZBEK U., Aydin-Sayitoglu M., SIRMA S. Ö., ÖZÇELİK T.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.129, no.10, pp.604-605, 2003 (SCI-Expanded)

AB0 blood subgroup allele frequencies in the Turkish population.

Akbas F., Aydin M., Cenani A.

Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur, vol.61, pp.257-60, 2003 (SCI-Expanded)

The value of TNF-alpha and IL-10 gene polymorphisms in the incidence and severity of graft-versus-host disease

ÖZBEK U., GURSES N., KALAYOGLU-BESISIK S., Aydin M., BILGEN H., ONGOREN S., et al.

BONE MARROW TRANSPLANTATION, vol.29, 2002 (SCI-Expanded)

Metabolising enzyme polymorphisms (GSTM1, GSTT1, CYP1A1, CYP2D6) and their association as a potential susceptibility to pediatric ALL.

Ozbek U., Aydin M., Hatirnaz O., Agaoglu L., Sirma S., Yuksel L., et al.

BLOOD, vol.98, no.11, 2001 (SCI-Expanded)

Cytokine gene polymorphism in patients with graft-versus-host disease after HLA-matched bone marrow transplantion.

ÖZBEK U., GURSES N., KALAYOGLU-BESISIK S., Aydin M., BILGEN H., ONGOREN S., et al.

BLOOD, vol.98, no.11, 2001 (SCI-Expanded)

Chimerism status in allo-pbsct versus allo-BMT: single center results

Uzbek U., Kalayoglu-Besisik S., Aydin M., Yenerel M. N., Aktan M., Budak T., et al.

Blood, vol.96, 2000 (SCI-Expanded)

Chimerism status in allo-PBSCT versus allo-BMT: Single center results.

Özbek U., Kalayoglu-Besısık S., Aydin M., Yenerel M. N., Aktan H., Budak T., et al.

BLOOD, vol.96, no.11, 2000 (SCI-Expanded)

Trombosit PLA2 Polimorfizmi ile Genç Hastalarda Koroner Arter Trombozu Arasındaki İlişkinin Araştırılması

KÜÇÜKKAYA R., AYDIN SAYİTOĞLU M., ÖNCÜL A., BÜYÜKÖZTÜRK K., CENANİ A., ÖZBEK U., et al.

İstanbul Tıp Fakültesi Mecmuası, vol.63, pp.4-5, 2000 (Peer-Reviewed Journal)

GSTT1 null genotype frequency in a Turkish population.

Oke B., Akbas F., Aydin M., Berkkan H.

Archives of toxicology, vol.72, pp.454-5, 1998 (SCI-Expanded) Sustainable Development

Papers Published in Refereed Scientific Meetings

hRgr overexpretion in human T cell malignancy

Burak İ., KARAKAŞ Z., SOYSAL T., SAYİTOĞLU M., Süzme R., ÖZBEK U.

Europian Human GeneticsConference 2015, 6 - 09 June 2015, (Full Text)

Makine Öğrenmesi Temelli Transkriptom Modeli Kullanarak Ph-Benzeri ALL Hastalarının Tespiti

Sun E., ULUCAN AÇAN Ö., ERBİLGİN Y., EŞKAZAN A. E., KARAKAŞ Z., SAYİTOĞLU M.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)

Çocuk Çağı Nüks Akut Lösemi Hastalarının Genetik ve Epigenetik Karakterizasyonu

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

39. Ulusal Hematoloji Kongresi, Turkey, 23 - 26 October 2013, (Summary Text)

ÇOCUKLUK ÇAĞI NÜKS AKUT LÖSEMİ HASTALARINDA TÜM GENOM ANALİZLERİ; ÖN BULGULAR

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., FIRTINA S., ÖZGÜVEN A. A., AĞAOĞLU ÜLGÜR F. L., et al.

38 Ulusal Hematoloji Kongresi, Turkey, 31 October 2012, (Summary Text)

ISTisNA Platform: A Comprehensive Biobank Network for Rare and Undiagnosed Diseases

Antmen F. M., KASAP B., Erdogan C., Kılıç M., Kocaaga S., Önder G., et al.

Europe Biobank Week Congress 2024, Viyana, Austria, 14 - 17 May 2024, (Summary Text)

Gene expression pattern in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targetss

ERBİLGİN Y., İslek B., Firtina S., HATIRNAZ NG Ö., Inal A., Dogan P., et al.

ESHG, Barselona, Spain, 20 - 22 May 2016, (Summary Text)

Gene expression patterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets

ERBİLGİN Y., İşlek B., Fırtına S., HATIRNAZ NG Ö., İnal A., Doğan P., et al.

European Society of Human Genetics 2016, Barselona, Spain, 21 - 24 April 2016, (Summary Text) Sustainable Development

PROGNOSTİC SİGNİFİCANCE OF IKZF1 DELETİONS İN CHİLDHOOD B ALL

ERBİLGİN Y., FIRTINA S., HATIRNAZ NG Ö., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

Bİ ANNUAL CHILDHOOD LEUKEMIA SYMPOSIUM, 25 April - 27 May 2016, (Summary Text)

Prognostic significance of IKZF1 Deletionsin Childhood B ALL

ERBİLGİN Y., Fırtına S., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T. T., SARPER N., et al.

10.th Biennial Childhood Leukemia Sypmosium, 24 - 26 April 2016, (Summary Text)

Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia

ERBİLGİN Y., HATIRNAZ NG Ö., FIRTINA S., Küçükcankurt F., KARAKAŞ Z., CELKAN T. T., et al.

European Human Genetics Virtual Conference 2021, Austria, 28 - 31 August 2021, (Summary Text)

PTEN AND AKT1 GENE VARIATIONS IN CHILDHOODT-ALL PATIENTS

Küçükcankurt F., HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., KARAKAŞ Z., CELKAN T. T., et al.

6th International Congress onLeukemia – Lymphoma – Myeloma, 11 - 13 May 2017, (Summary Text)

Çocukluk Çağı Nüks Akut Lösemi Hastalarında Tüm Genom Analizleri Ön Bulgular

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ N. Ö., FIRTINA S., ÖZGÜVEN A. A., AĞAOĞLU L., et al.

38. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012, (Summary Text)

Metabolising enzyme polymorphisms GSTM1 GSTT1 CYP1A1 CYP2D6 and their association as a potential susceptibility to pediatric ALL

ÖZBEK U., SAYİTOĞLU M., HATIRNAZ NG Ö., Ağaoğlu L., SIRMA EKMEKCİ S., Yüksel L., et al.

43rd American Society of Hematology Meeting, 7 - 11 December 2001

Çocukluk Çağı B-All Hastalarında Tanı Ve Nüks Anındaki Moleküler Değişimlerin Dinamiği

FIRTINA S., ERBİLGİN Y., TAŞAR O., MERCAN S., HATIRNAZ N. Ö., şişko s., et al.

43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

Lenfoma ve İmmünyetmezliğe Sahip İndeks Olguda Somatik ve Germline Varyasyonların Ekzom Dizi Analizi ile Analizi

Khodzhaev K., SARITAŞ M., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.

XIII. AZİZ SANCAR DENEYSEL TIP ARAŞTIRMA ENSTİTÜSÜ GÜNLERİ Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye, İstanbul, Turkey, 21 - 22 December 2021, vol.12, (Summary Text)

Çocukluk Çağı Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom SNP Array Analizi

ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., FIRTINA S., Can İ., ÜNÜVAR A., et al.

9 Ulusal Pediatrik Hematoloji Kongresi, Van, Turkey, 24 May 2013, pp.8, (Summary Text)

Glucocorticoid receptor gene polymorphisms and their relation with glucocorticoid sensitivity and obesity in patients with congenital adrenal hyperplasia

nurçin s., POYRAZOĞLU Ş., SAYİTOĞLU M., ÖZBEK U., Şen N., AKIN L., et al.

8.th joint meeting global care in pediatric endocrinology, New York, United States Of America, 9 - 12 September 2009

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Erbilgin Y., Ozden Hatirnaz Ng O. H. N., Firtina S., Celkan T., Anak S., Karakas Z., et al.

55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text)

Pediatrik ALL Hastalarında LEF1 Mutasyon Analizi

KÜÇÜKCANKURT F., ERBİLGİN Y., CAN İ., HATIRNAZ N. Ö., MERCAN S., şişko s., et al.

40. Ulusal Hematoloji Kongresi, Turkey, 22 - 25 October 2014, (Summary Text)

Determination of Zinc Finger Protein 384 (ZNF384) Gene Fusion in Childhood Acute Lymphoblastic Leukemia Patients

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAKAŞ Z., SARPER N., CELKAN T. T., et al.

13th Balkan Congress of Human Genetics, 17 - 20 April 2019, (Full Text)

Detection of T-cell Receptor Excision Circles (TRECs) in Dried Blood Spot (DBS) Implementation of Routine Newborn Screening For The Diagnosis of SCID,

NG Y. Y., FIRTINA S., HATIRNAZ N. Ö., KIYKIM A., AYDINER E., ÖZEN A. O., et al.

4. Klinik İmmünoloji Kongresi, Turkey, 11 - 14 April 2018, (Summary Text)

Diagnostics Of Primary Antibody Deficiencies Through Targeted Next Generation Sequencing Panel

NG Y. Y., FIRTINA S., HATIRNAZ N. Ö., camcıoğlu y., AYDINER E., KIYKIM A., et al.

International Primary Immunodeficiencies Congress, United Arab Emirates, 8 - 10 November 2017, (Summary Text)

Characterization of Hereditary Hemolytic Anemia cases in Turkey by Whole Exome Sequencing

Altındirek D., Tuğcu D., Karaman S., Erbilgin Y., Sayitoğlu M., Karakaş Z.

EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From Basic Science to Clinical Case Application, Budapest, Hungary, 12 - 14 October 2023, (Unpublished)

KONJENİTAL HEMOLİTİK ANEMİ HASTALARINDA TÜM EKZOM DİZİLEME İLE ADAY VARYANTLARIN BELİRLENMESİ

ALTINDİREK D., TUĞCU D., BİLİCİ M., KARAMAN S., ERBİLGİN Y., ÜNAL CANGÜL Ş., et al.

48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2022, (Full Text)

Çocukluk Çağı Lenfoma Hastalarında Germline Varyasyonlar ve Genetik Yatkınlık

Khodzhaev K., SUDUTAN T., ERBİLGİN Y., Ocak S., KIYKIM A., Altındirek D., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)

PATHWAYS ASSOCIATED WITH RELAPSE AND HIGH RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

ERBİLGİN Y., HATIRNAZ NG O., ISLEK B., FIRTINA S., CELKAN T. T., ANAK S. S., et al.

EUROPEAN HUMAN GENETICS CONFERENCE 2015 GLASGOW, SCOTLAND, UK, 6 - 09 June 2015, vol.23, (Full Text)

Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia

FIRTINA S., SAYİTOĞLU M., HATIRNAZ N. Ö., ERBİLGİN Y., ÖZTUNÇ C., ÇINAR S., et al.

Molecular Immunology Immunogenetics Congress, Turkey, 27 - 29 April 2012, (Summary Text)

Primer Antikor Yetmezlik Hastalarında Hastalığa Sebep Olan Varyantların Yeni Nesil Genetik Tanı Paneli ile Tespiti

FIRTINA S., NG Y. Y., HATIRNAZ NG Ö., camcıoğlu y., AYDINER E., KARA E. M., et al.

3. KLİNİK İMMÜNOLOJİ KONGRESİ, İzmir, Turkey, 12 - 15 April 2017, pp.90, (Summary Text)

Acute Leukemia: Diagnosis/prognosis: Molecular biology and genetics

SAYİTOĞLU M.

EHA-TSH tutorial on acute leukemia, 28 - 29 April 2018, (Full Text)

EXPRESSION AND IMMUNOHISTOCHEMICAL ANALYSIS OF AQUAPORINE GENES IN MESIAL TEMPORAL SCLEROSIS EXPRESSION AND IMMUNOHISTOCHEMICAL ANALYSIS OF AQUAPORINE GENES IN MESIAL TEMPORAL SCLEROSIS

Bebek N., Özdemir Ö., Sayitoglu M., Baykal B., Ozbek U., Karasu A., et al.

63rd Annual Meeting of the American-Epilepsy-Society, Massachusetts, United States Of America, 4 - 08 December 2009, vol.50, pp.302, (Summary Text)

Primer Antikor Yetersizliği Olan Hastalarda Saptanan Bruton Tirozin Kinaz (BTK) Gen Varyasyonları

FIRTINA S., NG Y. Y., HATIRNAZ N. Ö., HASKOLOĞLU Z. Ş., KIYKIM A., AYDINER E., et al.

XXIV. Ulusal İmmünoloji Kongresi, Turkey, 27 - 30 April 2017, (Summary Text)

Allelotype frequencies of TPMT (thiopurine S-methyltransferase), CYP3A4 and CYP3A5 genes in Turkish population

ÖZBEK U., Sayitoglu M., HATIRNAZ O.

5th International Symposium on Leukemia and Lymphoma, Amsterdam, Netherlands, 12 - 15 March 2003, vol.17, pp.679, (Summary Text)

PDL1 ve PDL2 genetik alterasyonu klinik HLda seyri belirler mi

SAYİTOĞLU M.

İstanbul Lenfoma Grubu Toplantısı, Turkey, 23 January 2016

Dignostics of primary antibody deficiencies through targeted next generation sequencing panel

NG Y. Y., Firtina S., HATIRNAZ NG Ö., Kara M., Somer A., CAMCIOĞLU Y., et al.

IPIC 2017, 8 - 10 November 2017, (Summary Text)

Molecular Dıagnosıs Of Scıd Patıents By A Custom Desıgned Targeted Next Generatıon Sequencıng Panel

FIRTINA S., SAYİTOĞLU M., HATIRNAZ N. Ö., KIYKIM A., AYDINER E., BARIŞ S., et al.

International Primary Immunodeficiencies Congress, United Arab Emirates, 8 - 10 November 2017, (Summary Text)

Yüksek FZ5 Ekspresyonu Beta-Catenin/TCF-LEF Kompleksinin Atipik Ekspresyonunu Arttırarak Akut Myeloid Lösemi Gelişiminde Rol Oynar

Atalar F., Sayitoğlu M., Hatirnaz Ng Ö., Erbilgin Y., Özbek U.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 8 - 12 November 2006, pp.76, (Full Text)

Research Biobank for Leukemia

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., khodzhaev k., ÖZBEK U., SAYİTOĞLU M.

Towards Harmony in Biobanking, 13 - 15 September 2017, (Summary Text)

Methylation status of the wnt antagonist DICKKOPF-1 gene in acute leukemias

ATALAR F., HATIRNAZ O., Sayitoglu M., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.403, (Summary Text)

Molecular Diagnosis of SCID patients by a Custom Designed NGS Panel

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., Karakoç Aydıner E., Barış S., et al.

IPIC 2017, Dubai, United Arab Emirates, 15 - 17 November 2017, (Summary Text)

Increased level of B-catenin mRNA and mutational alterations in APC gene are present in acute leukemia

ATALAR F., Sayitoglu M., HATIMAZ O., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.62, (Summary Text)

Molecular Diagnosis of SCID patients by a custom designated targeted next generation sequencing panel

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Baris S., et al.

IPIC 2017, 8 - 10 October 2017, (Summary Text)

AccessDistribution of Biospecimens: Practical Issues

ERBİLGİN Y.

International Workshop on Biobanking for Rare Diseases, 2 - 03 May 2018, (Full Text)

Ethical, Legal, and Social ImplicaKons (ELSI) of Biobanking in Turkey

ERBİLGİN Y.

ETHICAL, LEGAL AND SOCIETAL INSIGHTS & OUTLOOK FOR BIOBANKS AND MEDICAL RESEARCH, Lyon, France, 4 - 07 June 2024, (Summary Text)

KRONİK MİYELOİD LÖSEMİ HASTALARINDA FARKLI BCR::ABL1 TRANSKRİPTLERİNİN KLİNİK YANSIMALARI

Ordu M., Erbilgin Y., Yılmaz U., Eşkazan A. E., Altındirek D., Uğur İşeri S. A., et al.

48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, pp.126-127, (Full Text)

Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study

SOVERINI S., ERNST T., KOHLMANN A., DE BENEDITTIS C., ALIKIAN M., FORONI L., et al.

55.th ASH Meeting 2013, 7 - 10 December 2013, vol.122

Whole genome methylation profile of relapsed childhood leukemia, Translating Epigenomes into Function: a Next-Generation Challenge for Human Disease

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

FEBS Workshop, Germany, 13 - 16 October 2013, (Summary Text)

Pediatrik T ALL hastalarında regülatör mikroRNA ların yolak analizleri ile belirlenmesi

HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

14 Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2015, (Summary Text)

A new noncoding risk factor for ALL 8q24 region preliminary data

Ismail C., HATIRNAZ NG Ö., ERBİLGİN Y., Ceren O., SAYİTOĞLU M., ugur o., et al.

3rd EMBO meeting, Viyana, Austria, 11 - 13 September 2011

Pathways associated with relapse and high risk in childhood acute lymphoblastic leukemia

ERBİLGİN Y.

European Society of Human Genetics, Glasgow, United Kingdom, 6 - 09 June 2015, pp.445, (Full Text)

Pathways asociated with relapse and high risk in childhood acute lymphoblastic leukemia

ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., ANAK S. S., KARAKAŞ Z., SARPER N., et al.

ESHG 2015, 6 - 09 June 2015

Erişkin Primer İmmün Yetersizlikli Hastalarda Genetik Tanı

YILMAZ H., FIRTINA S., HATIRNAZ N. Ö., NG Y. Y., özmen D., KESKİN D., et al.

X.Aziz Sancar DETAE Günleri, Turkey, 29 - 30 November 2018, (Summary Text)

İÜ DETAE MOLEKÜLER HEMATOLOJİ ÇALIŞMA GRUBU 1996 2014 YILLARI LÖSEMİLERİN MOLEKÜLER MONİTORİZASYONU

SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., ALTINDİREK D., SERBEST E., SIRMA EKMEKCİ S., et al.

6. DETAE GÜNLERİ, Turkey, 24 - 25 November 2014

Comparative analysis of regenerative potential of dental pulp and dental follicle derived stem cells cultured on polycaprolactone scaffolds for bone tissue engineering approaches

Özcan E., ERBİLGİN Y.

23rd International Conference on Oral and Maxillofacial Surgery, 31 March - 03 April 2017, (Summary Text)

T-ALL OLGULARINDA NOTCH1 VE FBXW7 GEN MUTASYONLARININ ARAŞTIRILMASI

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., AR M. C., DOĞRU Ö., Aydoğan G., et al.

35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 07 October 2009, (Summary Text)

Potential diagnostic value of circulating miR-1183 and its target gene in early-onset preeclampsia

ALTINDİREK D., GÜNEL T., Benian A., Aydınlı K.

13th Balkan Congress of Human Genetics, Edirne, Turkey, 17 - 20 April 2019, pp.27, (Full Text)

Potential diagnostic value of circulating microRNA-1183 and CHURC1 gene in NIPD of preeclampsia

Altindirek D., Gunel T., Benian A., Aydinli K.

50th European-Society-of-Human-Genetics (ESHG) Conference, Copenhagen, Denmark, 27 - 30 May 2017, vol.26, pp.155, (Summary Text)

A Novel Candidate Gene for Predisposition of Hodgkin Lymphoma; Pregnan X Receptor (PXR)

KEBUDİ R., ERBİLGİN Y., Khodzhaev K., Sarıtaş M., BOZKURT C., SAYİTOĞLU M.

63RD ASH ANNUAL MEETING, United States Of America, 11 December 2021, (Full Text)

Derin Dizi Analizi ile Pediatrik Akut Lenfoblastik Lösemi Hastalarında TP53 Gen Mutasyonlarının Saptanması ve Prognostik Önemi

FIRTINA S., ERBİLGİN Y., HATIRNAZ N. Ö., CAN İ., KARAKAŞ Z., CELKAN T. T., et al.

39. Ulusal Hematoloji Kongresi, Turkey, 23 - 26 October 2013, (Summary Text)

HODGKİN LENFOMAYA KALITSAL YATKINLIK OLUŞTURAN YENİ BİR GEN: PREGNANE X RESEPTÖRÜ (PXR)

Sudutan T., Khodzhaev K., ERBİLGİN Y., SARITAŞ M., YEGEN G., Bozkurt C., et al.

50. Ulusal Hematoloji Kongresi, Turkey, 30 October 2024, (Summary Text)

Investing in the Future BIOBANK

ERBİLGİN Y., TUNCER F. N., Haryanyan G., Khodzhaev K., UĞUR İŞERİ S. A., ÖZBEK U.

European Biobank Week 2016, 13 - 16 September 2016

Mutations in AXIN1, APC and B-catenin Genes in T-cell Acute Leukemia Patients

SAYİTOĞLU M., ÖZBEK U., ERBİLGİN Y.

T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development, Mandelieu, France, 7 - 09 May 2010, pp.28, (Full Text)

Towards an Epilepsy Biobank

Haryanyan G., Özdemir Ö., Yücesan E., TUNCER F. N., Kesim F. Y., ERBİLGİN Y., et al.

Global Biobank Week, 13 - 15 September 2017, (Summary Text)

T-AKUT LENFOBLASTİK LÖSEMİ’DE TRANSKRİPTOM DİZİLEME ANALİZLERİ

Sun E., HATIRNAZ NG Ö., Firtina S., ERBİLGİN Y., SAYİTOĞLU M.

50. Ulusal Hematoloji KOngresi, Antalya, Turkey, 1 - 04 November 2017, pp.12, (Full Text)

General quality management system requirements for European biobanks focus on formalin fixed and paraffin embedded tissues

Bonin S., Stumptner C., Caboux E., wilde A. D., ERBİLGİN Y., Goethals S., et al.

European Biobank Week 2016, 13 - 16 September 2016

Kanda serbest dolaşan tümör cDNA’larının lenfoma alt gruplarının tanımlanmasında ve hastalık takibinde kullanımının araştırılması

ERBİLGİN Y.

44.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

Nadir Primer Antikor Yetersizliği Sebebi: Otozomal Resesif Hiper İmmünglobulin M Sendromlu Olgular

yılmaz h., FIRTINA S., HATIRNAZ N. Ö., NG Y. Y., özmen D., KESKİN D., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

Hereditary hemolytic anemia cases in Turkey by whole exome sequencing

Altındirek D., ERBİLGİN Y., KARAKAŞ Z., KARAMAN S., TUĞCU D., SAYİTOĞLU M.

EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects, Budapest, Hungary, 3 - 04 November 2023, (Full Text)

Pediatrik Akut Lösemi Hastalarında LEF1 Mutasyon Analizi

TOZAN F., ERBİLGİN Y., CAN İ., HATIRNAZ N. Ö., TAŞAR O., MERCAN S., et al.

6. DETAE Günleri, Turkey, 24 - 25 November 2014, (Summary Text)

Minimal Rezidüel Hastalıkta Moleküler Değerlendirme

SAYİTOĞLU M.

47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 04 November 2021, (Summary Text)

Does TUBB2A expression have a prognostic effect in childhood T-ALL patients

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.

6th International Congress on Leukemia Lymphoma Myeloma, 11 - 16 May 2017, (Summary Text)

NGS Diagnositcs and Research

SAYİTOĞLU M.

LEGEND (Leukemia Gene Discovery) COST action Workshop, 11 - 12 October 2019, (Full Text)

Akut Lösemili Hastalarda ’xx’xx Zinc Finger Protein 384’xx’xx (ZNF384) Geni Füzyonlarının Tespiti

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., SARPER N., CELKAN T. T., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Summary Text)

Hematolojik malignitelerde genetik belirteçler

ERBİLGİN Y., ÖZBEK U.

Ulusal Çocuk Genetik Sempozyumu, Turkey, 22 - 24 October 2015

TİROZİN KİNAZ İNHİBİTÖRLERİNE DİRENÇLİ KRONİK MİYELOİD LÖSEMİ HASTALARINDA YENİ NESİL DİZİLEME TEKNİĞİ İLE BCR-ABL1 KİNAZ BÖLGESİ MUTASYONLARININ TESPİTİ

ERBİLGİN Y., EŞKAZAN A. E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., FIRTINA S., et al.

39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 October 2013, (Summary Text)

Kanser Genetiği

SAYİTOĞLU M.

1. multidisipliner tıp ar-ge ve tıpta yenilikler sempozyumu, Hatay, Turkey, 8 - 10 May 2015

Foliküler Lenfomalı Hastalarda Foliküler Sitotoksik T Hücre Alt Grupları ve Fonksiyonları

Akboğa F., Kuyaş M. İ., HİNDİLERDEN F., YÖNAL HİNDİLERDEN İ., Gültürk E., ERBİLGİN Y., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)

TREC/KREC Kopya Sayılarının Otoimmün Hastalıklarda Araştırılması: İTP ve Hashimoto Tiroiditi Örnekleri

Şahin Kimyon Ö., Altındirek D., Durcan E., Elverdi T., Hatırnaz Ng Ö., Gönen M. S., et al.

47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021, (Unpublished)

Pediatrik T ALL hastalarında regulator mikroRNA ların yolak analizleri ile belirlenmesi

HATIRNAZ NG Ö., Khodzhaev K., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

42 Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016, (Full Text)

Çocukluk Çağı B-ALL Hastalarinda IKZF1 Delesyonlarinin Araştırılması

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., ÖZBEK U.

43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

DETAE Genç Araştırıcılar Toplantısı 2015

Fırtına S., HATIRNAZ NG Ö., Şişko S., Ng Y. Y., ÇINAR S., DENİZ G., et al.

Primer immün yetersizliklerde genetik alt yapının yeni dizileme yöntemi ile belirlenmesi., İstanbul, Turkey, 19 - 20 January 2015, pp.16-17, (Summary Text)

X-Linked Agammaglobulinemia (XLA) as a model disease for the development of molecular diagnostic and gene therapy for primary immunodeficiency. Türk İmmünoloji Dergisi 2012; 1 (17 Suppl Abstract Book): 77.

Ng Y. Y., ÇINAR S., Fırtına S., Ceyhan B., HATIRNAZ NG Ö., SAYİTOĞLU M., et al.

Molecular Immunology & Immunogenetics Congress, İstanbul, Turkey, 27 - 30 April 2012, pp.77, (Summary Text)

Gen expression paterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets

ERBİLGİN Y., İŞLEK B., FIRTINA S., HATIRNAZ NG Ö., İNAL A., DOĞAN P., et al.

ESHG, 24 - 27 May 2016, (Summary Text)

Outcomes of a Biobanking Initiative from Turkey: ‘Investing in the Future: BIOBANK

ERBİLGİN Y., TUNCER F. N., UĞUR İŞERİ S. A., Khodzhaev K., ÖZBEK U.

Global Biobank Week, 13 - 15 September 2017, (Summary Text)

Kronik Lenfoblastik Lösemi Olgularında ZAP-70 Gen Ekspresyonunun RQ-PCR Yöntemi ile Tesbiti ve Prognostik Önemi

Coskunpınar E., Ure U., Baslar Z., Sayitoğlu M., Hatirnaz Ng Ö., Atalar F., et al.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 08 November 2006, pp.78, (Full Text)

Kanser Genomunun Düzenlenmesi

SAYİTOĞLU M.

15. Ulusal Tıbbi Biyoloji KOngresi, Turkey, 26 - 29 October 2017, (Full Text)

Pathway Analizi Enrichment Analizi

ERBİLGİN Y.

Biyobankalamada Veri Analizi Yöntemleri Kursu, Turkey, 30 - 31 May 2016

Çocukluk Çağı B-All Gelişiminde Kanonik Olmayan Wnt Yolağı Prognoz ve Sağ Kalım İle İlişkili Olabilir

HATIRNAZ N. Ö., FIRTINA S., AKGÜN E., TAKA E., ERBİLGİN Y., CELKAN T. T., et al.

43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

Primer immün yetersizliklerde genetik alt yapının yeni dizileme yöntemi ile belirlenmesi

Fırtına S., Hatirnaz N., Şişko S., NG Y., ÇINAR S., DENİZ G., et al.

DETAE Genç Araştırıcılar Toplantısı, İstanbul, Turkey, 19 - 20 January 2015, pp.16-17, (Summary Text)

Primer antikor yetersizlik hastalarında moleküler tanı.

Şişko S., HATIRNAZ NG Ö., ÇINAR S., Barış S., Barlan I., Haskoloğlu Ş., et al.

DETAE Genç Araştırıcılar Toplantısı 2015, İstanbul, Turkey, 19 - 20 January 2015, pp.15-16, (Summary Text)

Gen Ekspresyon Verilerinin Meta-Analizi ile Pediatrik Akut Lenfoblastik Lösemi’xxde Nükse Özgü Belirteçlerin Tespiti

ERBİLGİN Y., Khodzhaev K., SAYİTOĞLU M.

45. Ulusal Hematoloji Kongresi, Turkey, 31 October - 02 November 2019, (Full Text)

Improve human derived sample quality grade in European biobanks focus on snap frozen tissues on behalf of BBMRI ERIC Working Group 1 in the Work plan Quality

Daidone M., Baldacchio S., Barros F., Becker K., Caboux E., wilde M. D., et al.

European Biobank Week 2016, 13 - 16 September 2016

C¸OCUKLUK C¸AGˆI B-ALL HASTALARINDA IKZF1 DELESYONLARININ ARAS¸TIRILMASI

ERBİLGİN Y., Firtina S., Khodzhaev K., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T., et al.

43 Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.13, (Summary Text)

Evaluating and Comparing the Survey Results of PhD Candidates and Supervisors about Doctoral Education at İstanbul University Institute of Graduate Studies in Health Sciences

Ertuğrul B., Soluk Tekkeşin M., Erdal M. S., Sayitoğlu M., Karakaş Z.

ORPHEUS 2022, İstanbul, Turkey, 12 - 14 May 2022, pp.1, (Full Text)

Çocukluk Çağı Lenfoma Hastalarında Germline Varyasyonlar ve Genetik Yatkınlık

Khozhaev K., Sudutan T., Erbilgin Y., Ocak S., Kıykım A., Altındirek D., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, pp.1-2, (Summary Text)

A translational perspective on diffuse large B-cell lymphoma

Erbilgin Y.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Erbilgin Y., Eskazan A. E., NG O. H., Salihoglu A., Elverdi T., Firtina S., et al.

55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text)

B HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ HASTALARINDA PAX5 GENİ MOLEKÜLER ANALİZLERİ

ÖZDEMİRLİ S., SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., MAVİ N., TİMUR Ç., et al.

35.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 7 - 10 November 2009

Elevated Trib2 with Notch1 activation in pediatric adult T ALL

ERBİLGİN Y., ÖZBEK U., M Hannon M., Lohan F., O Hagan K., Mills K., et al.

BRITISH JOURNAL OF HAEMATOLOGY, Glasgow, England, 2 - 04 December 2012, vol.157, pp.6, (Summary Text)

KML hastalarında Kemik İliği Fibrozu Gelişiminde Kalretikulin Gen Anlatımının Önemi

YALNIZ F. F., Khusan K., Salihoğlu A., Suzin T., HATIRNAZ NG Ö., Yurttaş N., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, (Full Text)

T-akut lenfoblastik lösemi (T-ALL) Hastalarında Yüksek TUBB2A Gen Anlatımı ve siRNA Aracılı Modülasyonu

Khodzhaev K., HATIRNAZ NG Ö., TUĞCU D., Ng Y. Y., ERBİLGİN Y., CELKAN T. T., et al.

13. Ulusal Tıbbi Genetik Kongresi, Turkey, 7 November - 11 October 2018, (Summary Text)

FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients

ATALAR F., SAYİTOĞLU M., HATIRNAZ O., ÖZBEK U.

30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.195, (Full Text)

Comprehensive analysis of transcriptomic portrait of T-cell acute lymphoblastic leukemia by RNA sequencing

Sun E., Ng O. H., Erbilgin Y., Firtina S., Sayitoglu M.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

Molecular Diagnosis of SCID Patients by a custom designed targeted next generation sequencing panel

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Barış S., et al.

IPIC 2017, 8 - 10 November 2017, (Summary Text)

Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom Analizleri

ERBİLGİN Y.

DETAE Genç Araştırıcılar Toplantısı, Turkey, 19 - 20 January 2015, (Summary Text)

coBTK Lentiviral Vektörü Uygulanan XLA Hasta Kök Hücreleri ile NOD/SCID Farelerde B hücre Gelişiminin Düzeltilmesi Ön Sonuçları

NG Y. Y., HATIRNAZ N. Ö., FIRTINA S., ÇINAR S., AKAR H. H., PATIROĞLU T., et al.

XXIV. Ulusal İmmünoloji Kongresi, Turkey, 27 - 30 April 2017, (Summary Text)

CD70 mutations in a family with affected CID indivuduals

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M.

Highlights of Bertinoro, Predisposition to hereditary Leukemia and Lymphoma Training School, 11 - 12 October 2019, (Full Text)

Hypomorfic JAK3 and IL2RG Mutations Presenting with a Predominantly Antibody DEficiency Phenotype

KIYKIM A., FIRTINA S., ye z., ee n., SAYİTOĞLU M., BARIŞ S., et al.

European Society for Immunodeficiencies (ESID) Meeting, İSKOÇYA, 11 - 14 November 2017, (Summary Text)

New CNV Regions Identified in ITP Provide Evidence for Genetic Predisposition

Ar M. C., Yucesan E., Yalniz F., Ng O. H., Salihoglu A., Berk S., et al.

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)

Erişkin Yaşta Tanı Alan X’xxe bağlı Hipomorfik İmmün Yetmezlik

Kıykım A., Fırtına S., Naim E., Barış S., SAYİTOĞLU M., AYDINER E., et al.

3. Klinik İmmünoloji Kongresi, Turkey, 12 - 15 April 2017, (Summary Text)

WNT pathway mutations in acute leukemia patients

Sayitoglu M., HATIMAZ O., ATALAR F., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)

“Çıplak” Ağır Kombine İmmün Yetmezlikli 2 Kardeşte Tanımlanan Yeni Foxn1 Mutasyonu

FIRTINA S., ÇİPE F., KIYKIM A., HATIRNAZ N. Ö., SUDUTAN T., AYDOĞMUŞ Ç., et al.

4. Klinik İmmünoloji Kongresi, Turkey, 11 - 14 April 2018, (Summary Text)

Detection of CD19, ICOS, TACI gene mutations in Turkish CVID patients

Şişko S., Kıykım A., Barış S., Karakoç Aydıner E E., Nepesov S., Hatırnaz Ng Ö., et al.

4th European Congress of Immunology Vienna 2015, Vienna, Austria, 6 - 09 September 2015, pp.96, (Summary Text)

Pre examination process requirements for European biobanks focus on venous whole blood

Linsen L., Baber R., Caboux E., Daidone M., ERBİLGİN Y., wilde A. D., et al.

European Biobank Week 2016, 13 - 16 September 2016

A Novel FBN1 Variant in A Large Marfan Family with High Penetrance of Aortic Features

ERBİLGİN Y., ÇEFLE K., ÖZTÜRK Ş., EKIJI L., KADIOĞLU P., Kocaağa S., et al.

Avrupa İnsan Genetiği Kongresi 2024, Berlin, Germany, 01 June 2024, (Summary Text)

Whole Genome Expression Profiling at Diagnosis Predicts Relapse in Childhood Acute Lymphoblastic Leukemia

ERBİLGİN Y., Khodzhaev K., SAYİTOĞLU M.

7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)

Malign Hematoloji Genomik ne ifade ediyor

SAYİTOĞLU M.

2. Deneysel Hematoloji Kongresi, Kayseri, Turkey, 16 - 19 April 2015

BCL11b Mutasyonuna Bağlı Kombine İmmün Yetmezliği Olan Bir Hastada Kazanılmış Hemofili

ŞAHİN Ş., KARAMAN S., ERBİLGİN Y., ASLANGER A. D., GEZDİRİCİ A., TUĞCU D., et al.

14. Ulusal Pediatrik Hematoloji Kongresi, Ankara, Turkey, 24 May 2023, (Summary Text)

Primer antikor yetersizlik hastalarında moleküler tanı. DETAE Genç Araştırıcılar Toplantısı 2015, .

Şişko S., HATIRNAZ NG Ö., ÇINAR S., Barış S., Barlan I., Haskoloğlu Ş., et al.

DETAE Genç Araştırıcılar Toplantısı 2015, İstanbul, Turkey, 19 - 20 January 2015, pp.15-16, (Summary Text)

Yaygın Değişken İmmün Yetersizlik Tanılı Hastalarda Yeni Nesil Dizileme Sistemi İle Saptanan Varyasyonlar

yılmaz h., FIRTINA S., HATIRNAZ N. Ö., KESKİN D., SADRİ S., ÖZGÜR YURTTAŞ N., et al.

43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

Geleceğe Yatırım BİYOBANKA Projesi kapsamında Biyobankalama Protokolleri

ERBİLGİN Y.

Biyobankada Protokol ve Kalite Çalıştayı, Turkey, 06 April 2016

Exploring Germline Variations and Predisposition in Childhood Lymphoma

Sudutan T., Khodhzaev K., Erbilgin Y., Altındirek D., Kocaağa S., Sarıtaş M., et al.

Avrupa İnsan Genetiği Kongresi (ESHG), Berlin, Germany, 01 May 2024, (Unpublished)

ÇOCUKLUK ÇAĞI T-HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ HASTALARINDA ARTMIŞ TUBB2A ANLATIMI TEDAVİ YANITINI BELİRLER

Khodzaev K., HATıRNAZ N. O., Tuğcu D., Erbilgin Y., CELKAN T., AYDOGAN G., et al.

50. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.298, (Full Text)

Wnt Sinyal İleti Yolunun T-Hücreli ve B-Hücreli Akut Lenfoblastik Lösemilerde Farklı Aktivasyonları

SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ERBİLGİN Y., ÖZBEK U.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, pp.75, (Full Text)

hRgr overexpression in human T cell malignancy

Burak İ., KARAKAŞ Z., SOYSAL T., SAYİTOĞLU M., Rafi S., ÖZBEK U.

European Society of Human Genetics Meeting, 6 - 09 June 2015

Kök hücre naklinde kimeriz izlemi

SAYİTOĞLU M.

Ulusal Kemik iliği Transplantasyonu ve kök hücre tedavileri kongresi, Antalya, Turkey, 14 - 17 April 2016, (Full Text)

KML monitorizasyonunda yeni bir kantitatif analiz, raporlama ve takip yazılımı:RETILE

HATIRNAZ NG Ö., OZDEMİR O., SAYİTOĞLU M., ÖZBEK U.

41. Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, pp.22, (Full Text)

Different activation of WNT signaling pathway in B-cell and T-cell acute leukemias.

Sayitoglu M., HATIRNAZ O., Erbilgin Y., Atalar F., Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)

Çocukluk Çağı B-ALL Hastalarında IKZF1 Delesyonlarının Araştırılması

ERBİLGİN Y., FIRTINA S., khodzhaev k., HATIRNAZ N. Ö., KARAKAŞ Z., CELKAN T. T., et al.

43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

Evaluating and Comparing the Survey Results of PhD Candidates and Supervisors about Doctoral

ERTUĞRUL B., ERDAL M. S., SOLUK TEKKEŞİN M., SAYİTOĞLU M., KARAKAŞ Z.

ORPHEUS, Turkey, 12 May 2022, (Summary Text)

Primer İmmün Yetmezliklerde Rutin Tanı Deneyimi: 2010-2016 Yılları Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Genetik Anabilim Dalı Verileri

Hatırnaz Ng Ö., Ng Y. Y., Şişko S., Çatal Tatonyan S., Firtina S., Sever Kaya D., et al.

3.Klinik İmmünoloji Kongresi, İzmir, Turkey, 12 April 2017 - 15 April 3017, (Summary Text)

The Anti-HIV Drug Nelfinavir Exhibits Synergistic Activity with Tyrosine Kinase Inhibitors and Circumvents TKI-Resistance Conferred By T315I-Mutated BCR-ABL

ERBİLGİN Y., Desterke C., Bennaceur Griscelli A., TURHAN A.

64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 - 13 December 2022, pp.3871-3872, (Full Text)

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

KOHLMANN A., MARTINELLI G., ALIKIAN M., ARTUSI V., AUBER B., BELICKOVA M., et al.

55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text)

Decreased WNT5A and FZ5 mRNA Levels contributes to Acute Lymphoblastic Leukemia (ALL)

SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ÖZBEK U.

30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.196, (Full Text)

INVESTIGATING THE EXPRESSION OF INFLAMMATION RELATED GENES IN TEMPORAL LOBE EPILEPSY PATHOGENESIS

Özdemir Ö., Bebek N., Sayitoglu A. M., Yucesan E., Gurses C., Karacan I., et al.

29th International Epilepsy Congress, Rome, Italy, 28 August - 01 September 2011, vol.52, pp.99, (Summary Text)

Immun Trombositopenide Genetik Yatkınlığa Neden Olan Kopya Sayısı Değişiklkil (CNV) Bölgelerinin Belirlenmesi.

SAYİTOĞLU M., Fırat F., Yücesan E., HATIRNAZ O., ÖNGÖREN Ş., SOYSAL T., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, pp.10, (Full Text)

Biyobankalarda Pre Analitik Süreçler ve Standartlar

ERBİLGİN Y.

Biyobankada Laboratuvar Süreçleri Kursu, Turkey, 27 May - 28 June 2016

Pediatrik T-ALL hastalarında regulatör mikro RNA ların yolak analizleri ile belirlenmesi

Khodzaev K., HATIRNAZ NG Ö., Erbilgin Y., ÖZBEK U., SAYİTOĞLU M.

14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, pp.55, (Full Text)

Epigenetic profile of early relapsed Childhood ALL

ERBİLGİN Y., AYDOGAN G., CELKAN T., SAYİTOĞLU M., HATIRNAZ N. Ö., KARAKAŞ Z., et al.

40 Ulusal Hematoloji Kongresi, Antalya, Turkey, 22 - 25 October 2014, pp.20, (Summary Text)

Downregulation of Sno SKIL gene in T ALL

HATIRNAZ NG Ö., Orcun T., Yuk Yin N., Ceren Ö., ERBİLGİN Y., SAYİTOĞLU M., et al.

5th International Leukemia Lymphoma Myeloma Meeting, İstanbul, Turkey, 21 - 23 May 2015

Primer antikor yetersizlik hastalarında Moleküler tanı.

Şişko S., HATIRNAZ NG Ö., ÇINAR S., Barış S., Barlan I., Haskoloğlu Ş., et al.

6. DETAE günleri; DETAE’nin 70. Yaşında hastalık ve sağlığa bakış, İstanbul, Turkey, 24 - 25 November 2014, pp.28, (Full Text)

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Erbilgin Y., Firtina S., NG O. H., CELKAN T., Karakas Z., Anak S. S., et al.

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)

Deciphering congenital hemolytic anemia: identifying causal variants in unresolved cases through whole exome sequencing

Altındirek D., Tuğcu D., Karaman S., Erbilgin Y., Ünal Cangül Ş., Küpesiz O. A., et al.

European Human Genetics Conference, Milan, Italy, 24 - 27 May 2025, pp.1-2, (Summary Text)

PEDIATRIC TEL-AML1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS SHOW INCREASED MN1 EXPRESSION

Yener M. D., NUMATA M., Ekmekci S., Aydın M., GROSVELD G., Ozbek U., et al.

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.633, (Summary Text)

Cytokine gene polymorphism in patients with graft-versus-host disease after HLA-matched bone marrow transplantion

özbek u., gürses n., kalayoğlu beşışık s., aydın M., bilgen h., öngören s., et al.

43th ASC Congree, Washington, United States Of America, 16 - 17 November 2001, vol.98, no.11, pp.361, (Full Text)

ÇOCUKLUK ÇAĞI NÜKS AKUT LÖSEMİDE GENOM BOYU METİLASYON ANALİZLERİ

ERBİLGİN Y., HATIRNAZ NG Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

40. Ulusal Hematoloji Kongresi, Turkey, 22 October 2014, (Summary Text)

EVALUATION OF TP53 MUTATIONS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): RESULTS FROM IRON (INTERLABORATORY ROBUSTNESS OF NEXT-GENERATION SEQUENCING) II STUDY

BRONZINI I., BRUGNOLETTI F., SPINELLI O., SALMOIRAGHI S., IACOBUCCI I., PERRICONE M., et al.

19th Congress of the European-Hematology-Association, Milan, Italy, 12 - 15 June 2014, vol.99, pp.4-5, (Summary Text)

Nadir Bir Anemi: Konjenital Diseritropoetik Anemi Tip1’de De Novo CDIN1 Gen Varyasyonu ve Birleşik Heterozigotluk

Altındirek D., TUĞCU D., ERBİLGİN Y., KARAMAN S., SAYİTOĞLU M., TANYILDIZ H. G., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, (Summary Text)

Çocukluk Çağı T Hücreli Akut Lenfoblastik Lösemi Hastalarında Artmış TUBB2A Anlatımı Tedavi Yanıtını Belirler

KHODZHAEV K., HATIRNAZ NG Ö., TUĞCU D., ERBİLGİN Y., CELKAN T. T., KARAKAŞ Z., et al.

43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

T- ALL hücre hatlarında SKIL geni ve hsa-miR223 fonksiyonel ilişkisi

HATIRNAZ O., Ng Y. Y., TASAR O., Öztunç C., ÖZBEK U., SAYİTOĞLU M.

14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, pp.52, (Full Text)

MOLECULAR DIAGNOSIS OF SCID PATIENTS BY A CUSTOM DESIGNED TARGETED NEXT GENERATION SEQUENCING PANEL

FIRTINA S., SAYİTOĞLU M., NG HATIRNAZ O., KIYKIM A., AYDINER E., BARIŞ S., et al.

ınternational Primary Immunodeficiencies Congress 2017, 8 - 10 November 2017, (Summary Text)

Pathways associated with relapse and high risk in childhood ALL

ERBİLGİN Y., HATIRNAZ NG Ö., Burak İ., Sinem F., Tiraje C., ANAK S. S., et al.

European Society of Human Genetics Meeting, Glasgow, England, 6 - 09 June 2015

FOLİKÜLER LENFOMALI HASTALARDA FOLİKÜLER SİTOTOKSİK T HÜCRELERİ

Akboğa F., Kuyaş M. İ., Hindilerden F., Yönal Hindilerden İ., Gültürk E., Erbilgin Y., et al.

26. Ulusal İmmünoloji Kongresi, Ankara, Turkey, 11 - 13 November 2023, pp.49, (Summary Text)

Ağır Kombine İmmün Yetmezlik Hastalarında TREC/KREC Analizleri ve Klnik Uyumunun Araştırılması

NG Y. Y., Firtina S., HATIRNAZ NG Ö., Nepesov S., Kıykım A., AYDINER E., et al.

3. Klinik İmmünoloji Kongresi, Turkey, 12 - 15 April 2017, (Summary Text)

ÇOCUKLUK ÇAĞI BİFENOTİPİK AKUT LÖSEMİ HASTALARINDA MOLEKÜLER BELİRTEÇLER VE PROGNOSTİK ÖNEMİ

KÜÇÜKCANKURT F., ERBİLGİN Y., Sudutan T., KARAKAŞ Z., KARAMAN S., ÖZDEMİR G. N., et al.

48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, (Full Text)

Downregulation of SnoN SKIL gene in T ALL

HATIRNAZ NG Ö., Orcun T., Yuk Yin N., ceren o., ERBİLGİN Y., SAYİTOĞLU M., et al.

European Society of Human Genetics Meeting, Glasgow, England, 6 - 09 June 2015

Kronik Miyeloid Lösemi Genetiği

SAYİTOĞLU M.

1. Ulusal Hemato-onkogenetik kongresi, Antalya, Turkey, 25 November 2021, (Summary Text)

TREC/KREC analysis and their clinical correlation an severe combined imune deficiency

HATIRNAZ NG Ö., Fırtına S., SAYİTOĞLU M., nepesov s., Kıykım A., AYDINER E., et al.

IPIC 2017, 8 - 10 October 2017, (Summary Text)

Nadir Hastalıklarda Araştıma

SAYİTOĞLU M.

Nadir Hastalıklar Günü Sempozyumu, İstanbul, Turkey, 29 February 2016

Primer Antikor Yetmezlik Hastalarında Hastalığa Sebep Olan Varyantların Yen Nesil Genetik Tanı Paneli ile Tespiti

Firtina S., NG Y. Y., HATIRNAZ NG Ö., CAMCIOĞLU Y., AYDINER E., Kara M., et al.

3. Klinik İmmünoloji Kongresi, Turkey, 12 - 15 April 2017, (Summary Text)

BCR-ABL TRANSKRİPTİNİN KANTİTATİF TAYİNİNDE ULUSLARARASI SKALAYA GEÇİŞ

HATIRNAZ NG Ö., ERBİLGİN Y., Çatal S., Öztunç C., Uğurel E., KARABULUT A., et al.

37. Ulusal Hematoloji Kongresi, Antalya, Turkey, 19 - 22 October 2011, (Summary Text)

Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets

Imeri J., Desterke C., Telliam G., Marcoux P., Sorel N., Sanekli S., et al.

64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 December - 13 November 2022, pp.12173-12174, (Summary Text)

Nörogenetik verinin analizi: İnteraktif eğitim ve uygulama- ACMG Klavuzu

ERBİLGİN Y.

Nadir Görülen Hastalıklar Sempozyumu ve Nörogenetik Kursu, Turkey, 31 May 2018, (Summary Text)

Normalization methods and analysis packages for 450k data analysis

ERBİLGİN Y.

High-Throughput Methylome Analysis & Its Impact on Human Health and Disease Workshop, İstanbul, Turkey, 31 May 2013, (Summary Text)

Primer Antikor Yetersizliği Olan Hastalarda Saptanan Bruton Kinaz (BTK) Gen Varyasyonları

Fırtına S., Yin Y., HATIRNAZ NG Ö., HASKOLOĞLU Z. Ş., Kıykım A., AYDINER E., et al.

24.Ulusal İmmünoloji Kongresi, Turkey, 27 - 30 April 2017, (Summary Text)

Yeni nesil dizileme yöntemi ile tanı ve nüks akut lösemi hastalarında Tp53 Mutasyonlarının araştırılması

FIRTINA S., CAN İ., HATIRNAZ N. Ö., ERBİLGİN Y., KARAKAŞ Z., CELKAN T. T., et al.

9. Ulusal Pediatrik Hematoloji Kongresi, Turkey, 24 - 28 May 2013, (Summary Text)

WNT5A gene expression and promoter methylation in acute leukemia patients

HATIMAZ O., Sayitoglu M., ATALAR F., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)

Nadir Bir Anemi: Konjenital Diseritropoetik Anemi Tip1’de De Novo CDIN1 Gen Varyasyonu ve Birleşik Heterozigotluk

Altındirek D., Tuğcu D., Erbilgin Y., Karaman S., Sayitoğlu M., Tanyıldız H. G., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, (Unpublished)

Down regulation of SnoN SKIL gene in T cell acute lymphoblastic leukemia

HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M., ÖZBEK U.

ESHG 2015, 6 - 09 June 2015

Next Generation Sequencing Of The BCR ABL1 Domain May Be Beneficial In Decision Makin

Emre E., ÖZBEK U., HATIRNAZ NG Ö., ERBİLGİN Y., SOYSAL T., SAYİTOĞLU M., et al.

55th Annual Meeting of the American-Society-of-Hematology, New Orleans, United States Of America, 7 - 10 December 2013, (Full Text)

Effect of methylenetetrahydrofolate reductase gene polymorphism on methotrexate toxicity after bone marrow transplantation

BESISIK S., GURSES N., CALISKAN Y., TARAKCI F., ÇİNE N., Aydin M., et al.

29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text)